Professor Alizadeh focuses on the architecture of research in the field of liquid biopsy technology as a method for monitoring lymphomas. The data examined relates to Hodgkin's and non-Hodgkin's diseases and the application of these tools for non-invasive tumor detection and genotyping for patient monitoring and risk assessment. He also hypothesizes about how these methods could be applied to therapy selection and improvement.